0000000000210352

AUTHOR

Rosa Ballester

showing 7 related works from this author

Contractile effects of arginine analogues on human internal thoracic and radial arteries

2000

Abstract Objectives: Plasma levels of endogenous guanidino-substituted analogues of L -arginine are increased in various pathologic conditions. In the present study we determined the effects of some of these compounds on basal and stimulated release of nitric oxide in human internal thoracic and radial arteries. Methods: Rings of human internal thoracic and radial arteries were obtained from 16 multiorgan donors. The rings were suspended in organ baths for isometric recording of tension. Results: N G -monomethyl L -arginine (10 –6 to 10 –3 mol/L) and N G ,N G -dimethyl L -arginine (10 –6 to 10 –3 mol/L) caused concentration- and endothelium-dependent contractions. Maximal force of contracti…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyContraction (grammar)AdolescentArginineInternal thoracic arteryIn Vitro TechniquesArginineNitric OxideGuanidinesNitric oxidechemistry.chemical_compoundThoracic ArteriesInternal medicinemedicine.arteryMolemedicineMethylguanidineHumansVasoconstrictor AgentsAnalysis of Variancebusiness.industryAnatomyMiddle AgedEndocrinologychemistryRadial ArteryRegression AnalysisFemaleSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessVasoconstrictionAcetylcholinemedicine.drugThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

The Eradication of Poliomyelitis in Spain: Projects, Obstacles, Achievements, Realities

2015

he main aim of our paper is to provide a historical approach to the complex process undertaken in Spain to achieve the official WHO certificate of polio eradication in 2002, within the framework of the initiatives launched in the WHO European Region. At the time of the first meeting of the European Regional Commission for the Certification of Poliomyelitis Eradication in 1996, the epidemiological situation and levels of vaccination cover (over 90%) enabled Spain, like other countries, to ensure compliance with the conditions set by the World Health Organization. This showed that the country, at the end of the twentieth century, had achieved high public health standards, which is remarkable …

Economic growthmedicine.medical_specialtyHealth (social science)business.industryHealth PolicyPublic healthlcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Grey literatureCertificationCommissionCertificateWorld Health OrganizationTwentieth centuryPoliticsHistory and Philosophy of ScienceSpainPoliomyelitis eradicationDevelopment economicsHealth careeradicationMedicinebusinessPoliomyelitisHygiea Internationalis: an Interdisciplinary Journal for the History of Public Health
researchProduct

La Asociación Europea contra la Poliomielitis y los programas europeos de vacunación

2012

La búsqueda de una respuesta europea al problema planteado por los brotes epidémicos de poliomielitis en las décadas centrales del siglo XX, desembocó en la creación de un organismo nuevo, la Asociación Europea contra la Poliomielitis en 1951. Los mecanismos de funcionamiento interno y las conexiones internacionales de dicha Asociación fueron subsidiarios de un determinado contexto socio-político que propiciaba este tipo de consorcios. Como muestra este trabajo, su labor en los dieciocho años de existencia fue decisiva para la articulación y el éxito alcanzado por las políticas sanitarias nacionales de inmunización masiva frente a la enfermedad.

Public healthorganismos sanitarios internacionalesInternational agenciesPolio vaccinationAsociación Europea contra la PoliomielitisVacunació antipoliomielíticaEuropean Association against Poliomyelitis20th centurypoliomielitisGeneral MedicineOrganització Mundial de la Salut (OMS)World Health Organization (WHO)Política sanitàriaSegle XXpolítica sanitariaOrganismes sanitaris internacionalsHistory and Philosophy of ScienceOrganización Mundial de la Salud (OMS)World Health Organisation (WHO)vacunación antipoliomielíticasiglo XXPoliomyelitis
researchProduct

U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade.

2001

Objective: We investigated the potentiating effect of U-46619, a synthetic analogue of thromboxane A2 (TXA2), on the adrenergic responses in human saphenous vein. Methods: Saphenous vein rings were obtained from 35 patients undergoing coronary artery bypass surgery. The rings were suspended in organ bath chambers for isometric recording of tension. Results: U-46619 (10−10–3×10−7 mol/l) produced concentration-dependent and endothelium-independent contractile responses. U-46619 (10−10 mol/l) potentiated the contractions elicited by electrical stimulation and potassium chloride, and produced leftward shifts of the concentration–response curve for noradrenaline. The TXA2 receptor antagonist SQ-…

Malemedicine.medical_specialtyDihydropyridinesNifedipinePhysiologymedicine.drug_classThromboxaneReceptors ThromboxaneAdrenergicIn Vitro TechniquesPotassium ChlorideThromboxane receptorThromboxane A2chemistry.chemical_compoundNorepinephrineThromboxane A2Physiology (medical)Internal medicinemedicineHumansVasoconstrictor AgentsSaphenous VeinAgedVoltage-dependent calcium channelDose-Response Relationship DrugChemistryCalcium channelDihydropyridineDrug SynergismMiddle AgedReceptor antagonistCalcium Channel BlockersElectric StimulationStimulation ChemicalEndocrinology15-Hydroxy-11 alpha9 alpha-(epoxymethano)prosta-513-dienoic AcidFemaleEndothelium VascularCardiology and Cardiovascular Medicinemedicine.drugCardiovascular research
researchProduct

Políticas sanitarias locales puestas a prueba: consultores, expertos, misiones internacionales y poliomielitis en España, 1950-1975 = Local health po…

2015

Aquest treball analitza les missions d'experts d'organismes sanitaris internacionals a Espanya destinades a informar sobre la situació, les activitats realitzades i les intervencions necessàries en la lluita contra la discapacitat física dels xiquets. El Pla Espanya-23 va ser l'instrument utilitzat per l'OMS i altres agències per a posar en marxa el procés de canvi en un país en transformació durant la llarga etapa de vigència de la dictadura franquista. El treball utilitza com a fonts informes inèdits d'experts de l'OMS, que van ser resultat de visites realitzades al país entre 1950 i 1975. L'abordatge metodològic va consistir en una anàlisi del discurs que es troba en les fonts i la seua …

poliomielitisexpertos OMSWHO expertrehabilitacióntwentieth centurysegle XX:CIENCIAS DE LA VIDA::Virología [UNESCO]rehabilitationrehabilitacióUNESCO::CIENCIAS DE LA VIDA::Virologíaexperts OMSUNESCO::HISTORIA::Historia por especialidades::Historia de la medicina:HISTORIA::Historia por especialidades::Historia de la medicina [UNESCO]UNESCO::CIENCIAS MÉDICAS ::Medicina interna::Enfermedades infecciosassiglo XX:CIENCIAS MÉDICAS ::Medicina interna::Enfermedades infecciosas [UNESCO]poliomyelitis
researchProduct

Effects of antidepressants in adrenergic neurotransmission of human vas deferens

2000

Objectives. To evaluate the effects of sertraline, fluoxetine, and amitriptyline on the contractile responses of the human vas deferens muscle elicited by norepinephrine, electrical field stimulation, and KCl, because the therapeutic action of antidepressants may be accompanied by sexual dysfunction related to the contractility of the vas deferens smooth muscle. Methods. Ring segments of the epididymal part of the vas deferens were taken from 32 elective vasectomies and mounted in organ baths for isometric recording of tension. We then studied the effects of sertraline, fluoxetine, and amitriptyline on the neurogenic and agonist-induced contractile responses. Results. Amitriptyline caused c…

Malemedicine.medical_specialtyNifedipineAdrenergic receptorAmitriptylineUrologyAdrenergicSynaptic TransmissionNorepinephrine (medication)Vas DeferensNifedipineCulture TechniquesFluoxetineSertralineInternal medicinemedicineHumansAmitriptylineSertralineFluoxetineDose-Response Relationship Drugbusiness.industryVas deferensCalcium Channel BlockersAntidepressive AgentsReceptors AdrenergicEndocrinologymedicine.anatomical_structureCalciumbusinessMuscle Contractionmedicine.drugUrology
researchProduct

Spain and the international scientific conferences on polio, 1940s-1960s

2010

The development of international health from a historical point of view has undergone major advances in recent times and constitutes a substantial part of the current agenda for historians of medicine. Within this framework, and focussing on a specific case study (international responses to poliomyelitis outbreaks in the 20th century), we explore the main actions and achievements of agencies such as the WHO and other private and international scientific organizations. Furthermore, this paper seeks to identify the Spanish presence and absence in these activities, their causes and consequences.

españaEconomic growthconferències internacionals sobre pòlioConferències internacionals sobre poliComitès d'experts de la OMSeducationEspaña:CIENCIAS DE LA VIDA::Inmunología ::Vacunas [UNESCO]poliomielitisConferencias internacionales sobre polioeuropean association against poliomyelitisassociació europea enfront de la poliomielitissegle XXPoliomielitisSegle XXinternational conferences on polioUNESCO::CIENCIAS DE LA VIDA::VirologíaHistory and Philosophy of ScienceMedicineEspanyaComités de expertos de la OMShealth care economics and organizationsUNESCO::CIENCIAS DE LA VIDA::Inmunología ::Vacunasbusiness.industryWHO expert committeesasociación europea frente a la poliomielitisInternational healthEuropean Association against Poliomyelitis20th centuryGeneral Medicine:CIENCIAS DE LA VIDA::Virología [UNESCO]Congresses as TopicHistory 20th Century:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseconferencias internacionales sobre polioPoliomyelitisespanyaSpaincomités de expertos de la OMSUNESCO::CIENCIAS MÉDICASAsociación europea frente a la poliomielitisInternational Conferences on Poliosiglo XXAssociació europea davant la poliomielitisbusinessSiglo XXWHO Expert CommitteesPoliomyelitis
researchProduct